AVTE

Aerovate Therapeutics, Inc. AVTE

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AVTE IGMS QNCX LABP BLI NVNO SURF IMDX RPHM MIRO
6M -97.09 % -1.55 % 152.41 % 578.40 % -40.59 % -91.47 % 60.95 % 68.70 % 4.60 % 78.42 %
YTD -97.15 % -79.55 % 94.68 % 430.79 % -55.39 % -88.44 % 31.24 % 149.79 % 9.64 % 0.00 %
1Y -99.52 % -89.67 % 114.04 % 562.72 % -78.87 % -87.42 % 1.90 % 169.44 % -76.67 % 5.33 %
3Y -99.37 % -94.11 % 531.03 % -79.65 % -98.17 % -92.20 % -86.09 % -9.35 % -74.62 % -77.76 %
5Y -99.66 % -97.93 % -87.38 % -80.89 % -98.17 % -95.53 % -88.22 % -87.62 % 21.33 % -77.76 %
10Y -99.66 % -94.77 % -88.87 % -80.89 % -98.17 % -99.73 % -91.97 % -96.40 % 21.33 % -77.76 %
From the beginning -99.66 % -94.77 % -88.87 % -80.89 % -98.17 % -99.73 % -91.97 % -96.40 % 21.33 % -77.76 %

Dividend

Aerovate Therapeutics, Inc.